Over 1.82 billion Covid vaccine doses administered in India: Govt

The country launched vaccination for all people aged above 45 years from April 1 last year

Topics
Coronavirus Tests | Coronavirus Vaccine | Omicron

Press Trust of India  |  New Delhi 

Vaccination
A woman receives a booster dose of Covaxin, at a vaccination centre in New Delhi (Photo: Reuters)

The total number of COVID-19 vaccine doses administered in the country crossed 182.51 crore on Thursday, the Union health ministry said.

More than 88 lakh (88,13,578) vaccine doses have so far been administered to beneficiaries in the age group of 12 to 14 years, it added.

Over 26 lakh (26,50,337) vaccine doses were administered till 7 pm on Thursday, the ministry said, adding that the daily tally is expected to go up with the compilation of the final reports by late night.

More than 2.22 crore (2,22,56,496) precaution doses have been administered to healthcare workers (HCWs), frontline workers (FLWs) and those aged above 60 years.

The countrywide drive was rolled out on January 16 last year, with the HCWs getting inoculated in the first phase. The of the FLWs started from February 2 last year.

The next phase of Covid vaccination commenced on March 1 last year for people above 60 years of age and those aged 45 and above with specified co-morbid conditions.

The country launched vaccination for all people aged above 45 years from April 1 last year.

The Centre then decided to expand the vaccination drive by allowing everyone above 18 years of age to be inoculated against the viral disease from May 1 last year.

The next phase of Covid vaccination commenced from January 3 this year for adolescents in the age group of 15-18 years.

The country began administering precaution doses of the vaccines to the HCWs, FLWs and those aged 60 years and above with comorbidities from January 10.

The inoculation of children aged 12-14 years started from March 16.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Read our full coverage on Coronavirus Tests
First Published: Thu, March 24 2022. 22:06 IST
RECOMMENDED FOR YOU